Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gemcitabine and carboplatin treatment in patients with relapsing ovarian cancer.
Sufliarsky J, Chovanec J, Svetlovska D, Minarik T, Packan T, Kroslakova D, Lalabova R, Helpianska L, Horvathova D, Sevcik L, Spacek J, Laluha A, Tkacova V, Malec V, Rakicka G, Magdin D, Jancokova I, Dorr A, Stresko M, Habetinek V, Koza I. Sufliarsky J, et al. Among authors: minarik t. Neoplasma. 2009;56(4):291-7. doi: 10.4149/neo_2009_04_291. Neoplasma. 2009. PMID: 19473054
Bacteremia and fungemia in cancer patients with venous catheters.
Kukucková E, Studená M, Trupl J, Svec J, Kunová A, Sufliarsky J, Sorkovská D, Minárik T, Sycová Z, Krcméry V Jr. Kukucková E, et al. Among authors: minarik t. Neoplasma. 1995;42(1):35-8. Neoplasma. 1995. PMID: 7617073
Breakthrough bacteraemic and fungaemic episodes during antimicrobial prophylaxis and therapy in cancer patients: analysis of risk factors, etiology, therapy and outcome in 123 episodes.
Spánik S, Krcméry V Jr, Trupl J, Ilavská I, Hel'pianska L, Drgona L, Salek T, Mardiak J, Kukucková E, Studená M, Pichna P, Oravcová E, Grey E, Koren P, Minárik T, Lacka J, Sufliarsky J. Spánik S, et al. Among authors: minarik t. Bratisl Lek Listy. 1996 Nov;97(11):652-9. Bratisl Lek Listy. 1996. PMID: 9117428
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer.
Ray-Coquard I, Cibula D, Mirza MR, Reuss A, Ricci C, Colombo N, Koch H, Goffin F, González-Martin A, Ottevanger PB, Baumann K, Bjørge L, Lesoin A, Burges A, Rosenberg P, Gropp-Meier M, Harrela M, Harter P, Frenel JS, Minarik T, Pisano C, Hasenburg A, Merger M, du Bois A; AGO Study Group-led GCIG/ENGOT Intergroup Consortium. Ray-Coquard I, et al. Among authors: minarik t. Int J Cancer. 2020 Jan 15;146(2):439-448. doi: 10.1002/ijc.32606. Epub 2019 Sep 6. Int J Cancer. 2020. PMID: 31381147 Free article. Clinical Trial.
36 results